Pharmacology News
Join Dr. Carlos on “Pharmacology Insights,” your source for the latest research and news on pharmacology, medications, and street drugs. Each episode delves into cutting-edge discoveries, practical applications, and the evolving landscape of both legal and illicit substances. Gain a deeper understanding of how drugs work, their impacts on health, and the latest trends in medication and drug use. Tune in for expert analysis and insightful discussions that keep you informed on all things pharmacological.
The Messy Truth About Antidepressants: Benefits, Risks, and the Limits of the Evidence
Antidepressants demonstrate modest but real benefits for moderate-to-severe depression, with large meta-analyses showing consistent advantages over placebo and meaningful improvements in function for many patients, yet these gains are often smaller than portrayed and heavily influenced by high placebo responses. The evidence base comes with important limitations, including publication bias, short trial durations, industry influence, and challenges in blinding, which can inflate perceived efficacy while understating long-term risks such as sexual dysfunction, emotional blunting, and weight gain reported more frequently in real-world surveys. Navigating antidepressants requires pragmatic humility: they are a valuable tool for the right person at the right time...
Why One ADHD Medication Hits Kids So Differently — And How Genetics Can Help
Artificial intelligence begins prescribing medications in Utah
Marijuana and emphysema
Ketamine and neurotoxicity
New study on lithium
Is low-dose quetiapine safe for insomnia?
How assessments can increase antidepressant prescriptions
Saffron being studied for insomnia
Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD.
IS THERE A DIFFERENCE BETWEEN THE INJECTABLE OR ORAL NALTREXONE AND TREATMENT
A LOOK AT BIRTH CONTROL TO DEPRESSION TO ANTIDEPRESSANTS
PRAMIPEXOLE FOR TREATMENT RESISTANT DEPRESSION
ABILIFY COULD LEAD TO GAMBLING ADDICTION
VARENICLINE POSSIBLY COULD HELP WITH ALCOHOL USE DISORDER
ANTIDEPRESSANTS DURING PREGNANCY MAY ALTER FETAL DEVELOPMENT
LEVETIRACETAM POSSIBLE ADJUNCT FOR BIPOLAR MANIA
A STUDY ON ANTIPSYCHOTICS
TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS
PSILOCYBIN USE SKYROCKETS
A POSSIBLE NEW TREATMENT FOR SCHIZOPHRENIA
ATOMOXETINE, AMPHETAMINES FOR SCHIZOPHRENIA STUDY
HOW SSRI MIGHT AFFECT HEART DEVELOPMENT
ANTIPSYCHOTICS HELPS WITH CANNABIS INDUCED PSYCHOSIS
CLOZAPINE AND HYPERSALIVATION
PIMAVANSERIN DOES IT HELP WITH SCHIZOPHRENIA AND NEGATIVE SYMPTOMS
CANNABIS AND HEART DISEASE
DR. MONCRIEFF HER NEW BOOK CHEMICALLY IMBALANCED
A BRIEF LOOK AT SOME NEW PSYCHEDELIC RESEARCH
WEIGHT LOSS DRUGS CAN HELP YOUR HEALTH IN MANY WAYS BUT THERE ARE CONCERNS
NEW ANTI-PSYCHOTIC FOR SCHIZOPHRENIA
WE LOOK AT ANTIPSYCHOTIC SIDE EFFECTS
A STUDY ON ANTIPSYCHOTICS
WE CHAT WITH DR. ARMSTRONG ABOUT PSYCHEDELICS
DR. GOMINAK DISCUSSES THE IMPORTANCE OF VITAMIN D AND SLEEP
LITHIUM COULD PREVENT HOSPITALIZATION
FDA REJECTS MDMA
CAN OZEMPIC HELP WITH ADDICTION
TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS AND WHAT TO DO ABOUT IT3
STUDY LOOKS AT MAINTENANCE OPIOID THERAPY BUPRENORPHINE
